{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:37:59Z","timestamp":1719902279328},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clinthera.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T00:01:45Z","timestamp":1478908905000},"page":"2684-2689.e1","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns and Trends in Scientific Research on Generic Drugs"],"prefix":"10.1016","volume":"38","author":[{"given":"Rut","family":"Lucas-Dominguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Vidal-Infer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Alonso-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Valderrama-Zuri\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Aleixandre-Benavent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.10.010_bib1","unstructured":"U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, 33rd ed. http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/UCM071436.pdf. Published 2013. Accessed September 22, 2015."},{"key":"10.1016\/j.clinthera.2016.10.010_bib2","unstructured":"U.S. Food and Drug Administration. Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments). http:\/\/www.fda.gov\/newsevents\/testimony\/ucm115033.htm. Published 2009. Accessed September 4, 2015."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2016.10.010_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40258-014-0145-2","article-title":"A systematic review of physicians\u2019 and pharmacists\u2019 perspectives on generic drug use: what are the global challenges?","volume":"13","author":"Toverud","year":"2015","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"10.1016\/j.clinthera.2016.10.010_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0976-500X.99438","article-title":"Physicians\u2019 and patients\u2019 opinions on the use of generic drugs","author":"Sicras-Mainar","year":"2012","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.clinthera.2016.10.010_bib5","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2008.758","article-title":"Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis","volume":"300","author":"Kesselheim","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2016.10.010_bib6","unstructured":"WHO. Health systems financing: the path to universal coverage. WHO. http:\/\/www.who.int\/whr\/2010\/10_summary_en.pdf?ua=1. Published 2010. Accessed September 22, 2015."},{"key":"10.1016\/j.clinthera.2016.10.010_bib7","unstructured":"Generic Pharmaceutical Association. 2014 Generic Drug Savings in the U.S. report. http:\/\/www.gphaonline.org\/gpha-media\/gpha-resources\/2014-generic-drug-savings-in-the-u-s-report\/. Published 2014. Accessed September 22, 2015."},{"key":"10.1016\/j.clinthera.2016.10.010_bib8","first-page":"612","article-title":"Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices","volume":"24","author":"Bower","year":"1987","journal-title":"J Fam Pract"},{"key":"10.1016\/j.clinthera.2016.10.010_bib9","series-title":"Guidelines for ATC Classification and DDD Assignment 2015","year":"2014"},{"key":"10.1016\/j.clinthera.2016.10.010_bib10","unstructured":"WHO. Global Health Observatory (GHO) data. WHO. http:\/\/www.who.int\/gho\/mortality_burden_disease\/en\/. Accessed January 8, 2016."},{"key":"10.1016\/j.clinthera.2016.10.010_bib11","unstructured":"Generic Pharmaceutical Association. Generic Drug Savings in the U.S. (Fourth Annual Edition: 2012). http:\/\/www.gphaonline.org\/media\/\/cms\/IMSStudyAug2012WEB.pdf. Published 2012. Accessed September 22, 2015."},{"issue":"8","key":"10.1016\/j.clinthera.2016.10.010_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/17425255.2012.690394","article-title":"Current regulatory approaches of bioequivalence testing","author":"Karalis","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2016.10.010_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/cpt.28","article-title":"Novel bioequivalence approach for narrow therapeutic index drugs","volume":"97","author":"Yu","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2016.10.010_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nbt.2528","article-title":"Scientific considerations in the review and approval of generic enoxaparin in the United States","volume":"31","author":"Lee","year":"2013","journal-title":"Nat Biotechnol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816307950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816307950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T10:47:02Z","timestamp":1542278822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816307950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0149291816307950"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.10.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns and Trends in Scientific Research on Generic Drugs","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}